The Aroon Indicator for BMA entered a downward trend on November 10, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 242 similar instances where the Aroon Indicator formed such a pattern. In 197 of the 242 cases the stock moved lower. This puts the odds of a downward move at 81%.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 66 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMA's RSI Indicator exited the oversold zone, 18 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for BMA just turned positive on November 10, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 40 of 42 cases over the following month. The odds of a continued upward trend are 90%.
Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.262). P/E Ratio (0.001) is within average values for comparable stocks, (13.480). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.194). Dividend Yield (0.033) settles around the average of (0.035) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.740).
The Tickeron Seasonality Score of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The 10-day moving average for FUSB crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where FUSB advanced for three days, in 117 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FUSB as a result. In 60 of 127 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
The Moving Average Convergence Divergence Histogram (MACD) for FUSB turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 22 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.
FUSB moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FUSB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
FUSB broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.878) is normal, around the industry mean (1.262). P/E Ratio (12.326) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.370) is also within normal values, averaging (1.190). Dividend Yield (0.017) settles around the average of (0.035) among similar stocks. P/S Ratio (2.313) is also within normal values, averaging (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating fairly steady price growth. FUSB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BMA | FUSB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | 31 | |
SMR RATING 1..100 | 1 | 64 | |
PRICE GROWTH RATING 1..100 | 75 | 49 | |
P/E GROWTH RATING 1..100 | 97 | 65 | |
SEASONALITY SCORE 1..100 | 15 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BMA's Valuation (14) in the Regional Banks industry is in the same range as FUSB (30). This means that BMA’s stock grew similarly to FUSB’s over the last 12 months.
BMA's Profit vs Risk Rating (2) in the Regional Banks industry is in the same range as FUSB (31). This means that BMA’s stock grew similarly to FUSB’s over the last 12 months.
BMA's SMR Rating (1) in the Regional Banks industry is somewhat better than the same rating for FUSB (64). This means that BMA’s stock grew somewhat faster than FUSB’s over the last 12 months.
FUSB's Price Growth Rating (49) in the Regional Banks industry is in the same range as BMA (75). This means that FUSB’s stock grew similarly to BMA’s over the last 12 months.
FUSB's P/E Growth Rating (65) in the Regional Banks industry is in the same range as BMA (97). This means that FUSB’s stock grew similarly to BMA’s over the last 12 months.
| BMA | FUSB | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | N/A |
| Stochastic ODDS (%) | 2 days ago 84% | 1 day ago 60% |
| Momentum ODDS (%) | 2 days ago 76% | 1 day ago 47% |
| MACD ODDS (%) | 2 days ago 90% | 1 day ago 44% |
| TrendWeek ODDS (%) | 2 days ago 76% | 1 day ago 46% |
| TrendMonth ODDS (%) | 2 days ago 79% | 1 day ago 56% |
| Advances ODDS (%) | 22 days ago 80% | 8 days ago 53% |
| Declines ODDS (%) | 6 days ago 78% | 2 days ago 49% |
| BollingerBands ODDS (%) | 2 days ago 81% | 1 day ago 35% |
| Aroon ODDS (%) | 2 days ago 81% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMA’s FA Score shows that 3 FA rating(s) are green while FUSB’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMA’s TA Score shows that 5 TA indicator(s) are bullish while FUSB’s TA Score has 3 bullish TA indicator(s).
BMA (@Regional Banks) experienced а -3.87% price change this week, while FUSB (@Regional Banks) price change was -1.32% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was -1.23%. For the same industry, the average monthly price growth was +2.41%, and the average quarterly price growth was +11.80%.
BMA is expected to report earnings on Nov 25, 2026.
Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DFAW | 83.74 | 1.00 | +1.21% |
| Dimensional World Equity ETF (DFAW) | |||
| ETHV | 30.36 | 0.34 | +1.13% |
| VanEck Ethereum ETF (ETHV) | |||
| QMID | 30.33 | 0.22 | +0.73% |
| WisdomTree U.S. MidCap Quality Growth Fund (QMID) | |||
| JIII | 48.46 | 0.05 | +0.10% |
| Janus Henderson Income ETF | |||
| CCSB | 19.53 | 0.01 | +0.05% |
| Carbon Collective Short Duration Green Bond ETF (CCSB) | |||